Dr Craig Lee Reitz, MD | |
4205 Mcauley Blvd, #375, Oklahoma City, OK 73120-9391 | |
(405) 751-4343 | |
(405) 751-4346 |
Full Name | Dr Craig Lee Reitz |
---|---|
Gender | Male |
Speciality | Medical Oncology |
Experience | 45 Years |
Location | 4205 Mcauley Blvd, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881635852 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 12737 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospice | Oklahoma city, OK | Hospice |
Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
St Mary's Regional Medical Center | Enid, OK | Hospital |
Share Medical Center | Alva, OK | Hospital |
Mercy Hospital Ada | Ada, OK | Hospital |
Integris Bass Baptist Health Center | Enid, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mercy Clinic Oklahoma Communities | 1153468921 | 485 |
News Archive
Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, announced today that Healthy Lifestyles, Healthy Communities will provide free medical and dental services to more than 5,000 children and their caregivers in five cities throughout the United States this summer and fall.
IMRIS Inc. today officially launched VISIUS Surgical Theatre, its new global product branding at the Congress of Neurological Surgeons (CNS) being held in Washington DC.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
Recent COVID-19 investigations have found that up to half of immunocompromised individuals struggle to produce antibodies after receiving their severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations.
› Verified 8 days ago
Entity Name | Mercy Clinic Oklahoma Communities |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, announced today that Healthy Lifestyles, Healthy Communities will provide free medical and dental services to more than 5,000 children and their caregivers in five cities throughout the United States this summer and fall.
IMRIS Inc. today officially launched VISIUS Surgical Theatre, its new global product branding at the Congress of Neurological Surgeons (CNS) being held in Washington DC.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
Recent COVID-19 investigations have found that up to half of immunocompromised individuals struggle to produce antibodies after receiving their severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Craig Lee Reitz, MD 4401 W Memorial Rd, Suite 140, Oklahoma City, OK 73134-1785 Ph: (405) 752-3162 | Dr Craig Lee Reitz, MD 4205 Mcauley Blvd, #375, Oklahoma City, OK 73120-9391 Ph: (405) 751-4343 |
News Archive
Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, announced today that Healthy Lifestyles, Healthy Communities will provide free medical and dental services to more than 5,000 children and their caregivers in five cities throughout the United States this summer and fall.
IMRIS Inc. today officially launched VISIUS Surgical Theatre, its new global product branding at the Congress of Neurological Surgeons (CNS) being held in Washington DC.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
Recent COVID-19 investigations have found that up to half of immunocompromised individuals struggle to produce antibodies after receiving their severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations.
› Verified 8 days ago
Evelyn Lorents, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |